Finance

Lists
1177:HKG
Sino Biopharmaceutical Ltd
HK$5,25
-0,38%
(-0,020) 1D
16 ຕ.ລ., 16 ໂມງ 8 ນາທີ 14 ວິນາທີ GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
HK$5,40
High
HK$5,50
Low
HK$5,14
Mkt. cap
98,09 ຕື້
Avg. vol.
69,33 ລ້ານ
Volume
83,88 ລ້ານ
Dividend
2,29%
Quarterly dividend
HK$0,03
Ex-dividend date
29 ສ.ຫ. 2025
P/E ratio
33,86
52-wk high
HK$7,79
52-wk low
HK$4,19
EPS
HK$0,16
Shares outstanding
12,64 ຕື້
No. of employees
23 ພັນ
Open
HK$5,40
High
HK$5,50
Low
HK$5,14
Mkt. cap
98,09 ຕື້
Avg. vol.
69,33 ລ້ານ
Volume
83,88 ລ້ານ
Dividend
2,29%
Quarterly dividend
HK$0,03
Ex-dividend date
29 ສ.ຫ. 2025
P/E ratio
33,86
52-wk high
HK$7,79
52-wk low
HK$4,19
EPS
HK$0,16
Shares outstanding
12,64 ຕື້
No. of employees
23 ພັນ
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
1 ຊົ່ວໂມງກ່ອນ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
Yahoo Finance
·
14 ຊົ່ວໂມງກ່ອນ
Michael Burry Warns of a Stock Market ‘Supervolcano’
Seeking Alpha
Seeking Alpha
·
3 ຊົ່ວໂມງກ່ອນ
SH: A Tactical Hedge, But Not Yet A Short Call (NYSEARCA:SH)
Profile
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
CEOLi Yi
Employees22,8 ພັນ
Founded2000
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
7,13 ຕື້
7,13 ຕື້
9,72 ຕື້
9,72 ຕື້
Cost of goods sold
1,31 ຕື້
1,31 ຕື້
1,65 ຕື້
1,65 ຕື້
Cost of revenue
1,31 ຕື້
1,31 ຕື້
1,65 ຕື້
1,65 ຕື້
Research and development expenses
2,93 ຕື້
2,93 ຕື້
1,54 ຕື້
1,54 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,80 ຕື້
2,80 ຕື້
3,11 ຕື້
3,11 ຕື້
Operating expense
4,38 ຕື້
4,38 ຕື້
4,77 ຕື້
4,77 ຕື້
Total operating expenses
5,69 ຕື້
5,69 ຕື້
6,42 ຕື້
6,42 ຕື້
Operating income
1,44 ຕື້
1,44 ຕື້
3,31 ຕື້
3,31 ຕື້
Other non operating income
97,99 ລ້ານ
97,99 ລ້ານ
76,64 ລ້ານ
76,64 ລ້ານ
EBT including unusual items
488,22 ລ້ານ
488,22 ລ້ານ
3,67 ຕື້
3,67 ຕື້
EBT excluding unusual items
1,55 ຕື້
1,55 ຕື້
3,56 ຕື້
3,56 ຕື້
Income tax expense
323,77 ລ້ານ
323,77 ລ້ານ
597,96 ລ້ານ
597,96 ລ້ານ
Effective tax rate
66,32%
66,32%
16,29%
16,29%
Other operating expenses
-1,35 ຕື້
-1,35 ຕື້
113,21 ລ້ານ
113,21 ລ້ານ
Net income
-522,62 ລ້ານ
-522,62 ລ້ານ
1,72 ຕື້
1,72 ຕື້
Net profit margin
-7,33%
-7,33%
17,66%
17,66%
Earnings per share
-
-
-
-
Interest and investment income
196,36 ລ້ານ
196,36 ລ້ານ
250,06 ລ້ານ
250,06 ລ້ານ
Interest expense
-77,56 ລ້ານ
-77,56 ລ້ານ
-84,75 ລ້ານ
-84,75 ລ້ານ
Net interest expenses
118,80 ລ້ານ
118,80 ລ້ານ
165,31 ລ້ານ
165,31 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 ຕື້
1,66 ຕື້
3,57 ຕື້
3,57 ຕື້
Gain or loss from assets sale
-5,58 ລ້ານ
-5,58 ລ້ານ
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google